Amyloid β-peptides Aβ1-40 and Aβ1-42 induce cerebrovascular endothelial dysfunction

被引:0
作者
Thomas, T
McLendon, C
Tugertimur, A
Thomas, K
机构
[1] Woodlands Med & Res Ctr, Oldsmar, FL 34677 USA
[2] NYU, Methodist Hosp, Brooklyn, NY USA
[3] Univ Miami, Coll Med, Miami, FL 33152 USA
来源
ALZHEIMERS REPORTS | 1998年 / 1卷 / 01期
关键词
Alzheimer's disease; amyloid angiopathy; antioxidants; beta-amyloid; cerebrovascular; endothelium; free radicals; neurodegenerative disease;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cerebrovascular deposits of amyloid beta-peptides (A beta) leading to amyloid angiopathy is a prominent feature of Alzheimer's disease (AD). But cerebrovascular lesions in AD are usually neglected and the focus of most recent research efforts has been on genetic factors and the neurotoxicity of A beta. Recently we demonstrated that in vitro or in vivo application of A beta produced vascular endothelial damage and an inflammatory response through the production of free radicals. To probe the differential cerebrovascular actions of the major A beta-peptides used in AD research, we used an in vitro paradigm in which low concentrations of soluble A beta-peptides were introduced into a medium containing physiologically viable bovine cerebral arteries. The major endogenous C-terminal variants of A beta (A beta(1-40) or A beta(1-42)) induced characteristic features of endothelial dysfunction such as enhanced vasoconstriction and diminished vasodilation. The synthetic neurotoxic peptide A beta(25-35) had no significant effect on the vascular endothelium. This illustrates that the vascular actions of A beta are distinct from the previously reported neurotoxic properties of these peptides. The antioxidants superoxide dismutase and n-tertiary-butyl-alpha-phenylnitrone (PBN) protected the endothelium from A beta toxicity suggestive of an oxygen radical mediated phenomenon. If uncontrolled, the endothelial damage can trigger neurodegeneration in circumscribed regions by ischemic or inflammatory mechanisms. Drugs specifically targeting A beta(1-42) may not accord the desired protection against amyloid toxicity as A beta(1-40) of cerebral or peripheral origin can still induce deleterious effects of A beta. The possibility that A beta-induced vascular dysfunction may be an early event in the neurodegenerative process offers new avenues for therapy.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 50 条
  • [41] Amyloid-β1-40 Inhibits Amyloid-β1-42 Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Degeneration
    Bate, Clive
    Williams, Alun
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 985 - 993
  • [42] Plasma betacarotene in Alzheimer's disease.: Association with cerebrospinaffluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau
    Stuerenburg, HJ
    Ganzer, S
    Müller-Thomsen, T
    NEUROENDOCRINOLOGY LETTERS, 2005, 26 (06) : 696 - 698
  • [43] Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements
    Andreasson, Ulf
    Kuhlmann, Julia
    Pannee, Josef
    Umek, Robert M.
    Stoops, Erik
    Vanderstichele, Hugo
    Matzen, Anja
    Vandijck, Manu
    Dauwe, Martine
    Leinenbach, Andreas
    Rutz, Sandra
    Portelius, Erik
    Zegers, Ingrid
    Zetterberg, Henrik
    Blennow, Kaj
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (12) : 2058 - 2066
  • [44] Stability of Plasma Amyloid-β 1-40, Amyloid-β 1-42, and Total Tau Protein over Repeated Freeze/Thaw Cycles
    Liu, Huei-Chun
    Chiu, Ming-Jang
    Lin, Chin-Hsien
    Yang, Shieh-Yueh
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2020, 10 (01) : 46 - 55
  • [45] The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone
    Delaby, Constance
    Estelles, Teresa
    Zhu, Nuole
    Arranz, Javier
    Barroeta, Isabel
    Carmona-Iragui, Maria
    Illan-Gala, Ignacio
    Santos-Santos, Miguel Angel
    Altuna, Miren
    Sala, Isabel
    Sanchez-Saudinos, M. Belen
    Videla, Laura
    Valldeneu, Silvia
    Subirana, Andrea
    Tondo, Mireia
    Blanco-Vaca, Francisco
    Lehmann, Sylvain
    Belbin, Olivia
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    Alcolea, Daniel
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [46] Mechanisms of Ultrasonically Induced Fibrillation of Amyloid β1-40 Peptides
    Uesugi, Kentaro
    Ogi, Hirotsugu
    Fukushima, Masahiko
    So, Masatomo
    Yagi, Hisashi
    Goto, Yuji
    Hirao, Masahiko
    JAPANESE JOURNAL OF APPLIED PHYSICS, 2013, 52 (07)
  • [47] Admission Levels of Total Tau and β-Amyloid Isoforms 1-40 and 1-42 in Predicting the Outcome of Mild Traumatic Brain Injury
    Hossain, Iftakher
    Mohammadian, Mehrbod
    Takala, Riikka S. K.
    Tenovuo, Olli
    Gil, Leire Azurmendi
    Frantzen, Janek
    van Gils, Mark
    Hutchinson, Peter J.
    Katila, Ari J.
    Maanpaa, Henna-Riikka
    Menon, David K.
    Newcombe, Virginia F.
    Tallus, Jussi
    Hrusovsky, Kevin
    Wilson, David H.
    Gill, Jessica
    Blennow, Kaj
    Sanchez, Jean-Charles
    Zetterberg, Henrik
    Posti, Jussi P.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [48] Distinct secretases, a cysteine protease and a serine protease, generate the C termini of amyloid β-proteins Aβ1-40 and Aβ1-42, respectively
    Figueiredo-Pereira, ME
    Efthimiopoulos, S
    Tezapsidis, N
    Buku, A
    Ghiso, J
    Mehta, P
    Robakis, NK
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 (04) : 1417 - 1422
  • [49] Prevention of Amyloid-β Fibril Formation Using Antibodies Against the C-terminal Region of Amyloid-β1-40 and Amyloid-β1-42
    Montanes, Maria
    Casabona, Diego
    Sarasa, Leticia
    Pesini, Pedro
    Sarasa, Manuel
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (01) : 133 - 137
  • [50] Design of peptides that form amyloid-like fibrils capturing amyloid β1-42 peptides
    Sato, Junichi
    Takahashi, Tsuyoshi
    Oshima, Hideo
    Matsumura, Sachiko
    Mihara, Hisakazu
    CHEMISTRY-A EUROPEAN JOURNAL, 2007, 13 (27) : 7745 - 7752